Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Thermo Fisher Scientific IncTMO32.014.623.9920.3012.94%5.02%60.25$531.41$1,564.2639,072$512.88

Detail of Thermo Fisher Scientific Inc

 
CEO
Mr. Marc N. Casper
Employees
122000
Industry
Diagnostics & Research
Sector
Healthcare
Market cap
$196B

Company details

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OI
OIE
PI
TAX
NI
Revenue (Rev)
$42.37B
Cost of goods (CoG)
-$25.10B
Gross profit (GP)
$17.27B
Operating expense (OE)
-$9.87B
Research and development (R&D)
-$1.34B
General and administrative (G&A)
-$8.52B
Operating income (OI)
$7.41B
Other income expense (OIE)
-$265.00M
Pretax income (PI)
$6.84B
Tax (TAX)
-$641.00M
Net income (NI)
$6.12B
Thermo Fisher Scientific Inc
TMO • XNYS • US
$512.88
+30.45 (6.31%)
Stock vs Industry average
  • Industry average

Dividend yield
0.30%
Trailing annual dividend rate
$1.52
Payout ratio
9.53%
EPS
$16.02
Margin profit
14.48%
52 week low
$485.920013
52 week high
$626.380005
50-day simple moving average
$521.81
200-day simple moving average
$531.41
Percent held by insiders
0.18%
Percent held by institutions
91.37%
Dividend yield
0.28%

Change of shares

Cash vs Debt

Insider Trading

Comparison of selected companies

 
%
Price change
TMO +5.19%
eps change
TMO -4.05%